TNF and neoplasm: The authors concluded that SFRT producing the combination of enhanced induction of TNFα with its tumor killing and radiation sensitization effect together with the downregulation of TFG-β1 conferring a protective effect on normal tissues may provide the most advantageous therapeutic gain factor in allowing treatment of large and bulky tumors that exceed the potential for control with conventional radiation treatments [60].